Skip to main content

Advertisement

SpringerLink
Log in

Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study aims to report the concomitant diseases observed and damage outcome in a cohort of patients with adult idiopathic inflammatory myositis (IIM) during long-term follow-up. All patients with IIM were identified from a single centre (follow-up between 1979 and 2006) and fulfilled at least three of the four Bohan and Peter criteria. Patients with inclusion body myositis, juvenile-onset myositis and overt overlap syndromes were excluded. Medical notes were retrospectively reviewed. Concomitant diseases identified were divided into 12 different organ systems (bone, cardiac, respiratory, gastrointestinal, renal, central nervous, malignancy, infection, endocrine, eyes, dermatological and haematological). Patient damage index was calculated using the Myositis Damage Index tool. Fifty-five patients (31 polymyositis, 24 dermatomyositis) were identified. The most prevalent organ system involved was lung with 40 events per 1,000 patient years follow-up. There was significant steroid-related complications with 17/18 patients with bone involvement having osteopenia/osteoporosis. Sjogren's syndrome (n = 3) was the most frequent concomitant auto-immune disease observed. Patients with a higher number of organ systems involved had a significantly higher damage index (r = 0.48, p = 0.001). White patients showed a significant trend to develop more than three other organ system involvement (p < 0.0001) and myositis-related lung disease (p < 0.0001) compared to other races. There is significant steroid-related morbidity in adult IIM patients under long-term follow-up. The prevalence of another concomitant auto-immune disease unlike patients with lupus or Sjogren's syndrome is low.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ehrenstein MR, Snaith ML, Isenberg DA (1992) Idiopathic myositis: a rheumatological view. Ann Rheum Dis 51(1):41–44

    Article  PubMed  CAS  Google Scholar 

  2. Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 41(1):22–26

    Article  CAS  Google Scholar 

  3. Marie I, Hachulla E, Hatron PY et al (2001) Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors of prognosis. J Rheumatol 28(10):2230–2237

    PubMed  CAS  Google Scholar 

  4. Ponyi A, Borgulya G, Constantin T, Vancsa A, Gergely L, Danko K (2005) Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis. Rheumatology (Oxford) 44(1):83–88

    Article  CAS  Google Scholar 

  5. Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25(2):234–239

    Article  PubMed  CAS  Google Scholar 

  6. Torres C, Belmonte R, Carmona L et al (2006) Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 39(3):205–215

    Article  PubMed  Google Scholar 

  7. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM (1996) Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 14(3):263–274

    PubMed  CAS  Google Scholar 

  8. Tymms KE, Webb J (1985) Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 12(6):1140–1148

    PubMed  CAS  Google Scholar 

  9. Rios G (2005) Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies. J Clin Rheumatol 11(3):153–156

    Article  PubMed  Google Scholar 

  10. Uthman I, Vázquez-Abad D, Senécal JL (1996) Distinctive features of idiopathic inflammatory myopathies in French Canadians. Semin Arthritis Rheum 26(1):447–458

    Article  PubMed  CAS  Google Scholar 

  11. McDonagh JE, Isenberg DA (2000) Development of additional autoimmune diseases in a population of patients with systemic lupus erythematosus. Ann Rheum Dis 59(3):230–232

    Article  PubMed  CAS  Google Scholar 

  12. Chambers SA, Charman SC, Rahman A, Isenberg DA (2007) Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality. Ann Rheum Dis 66(9):1173–1177

    Article  PubMed  CAS  Google Scholar 

  13. Lazarus MN, Isenberg DA (2005) Development of additional autoimmune diseases in a population of patients with primary Sjogren's syndrome. Ann Rheum Dis 64(7):1062–1064

    Article  PubMed  CAS  Google Scholar 

  14. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344–347

    PubMed  CAS  Google Scholar 

  15. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403–407

    PubMed  CAS  Google Scholar 

  16. Vitali C, Bombardieri S, Moutsopoulos HM et al (1993) Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36(3):340–347

    Article  PubMed  CAS  Google Scholar 

  17. Clarke AE, Bloch DA, Medsger TA Jr, Oddis CV (1995) A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 38(9):1218–1224

    Article  PubMed  CAS  Google Scholar 

  18. Bronner IM, van der Meulen MF, de Visser M et al (2006) Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 65(11):1456–1461

    Article  PubMed  CAS  Google Scholar 

  19. Marie I, Hachulla E, Cherin P et al (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 47(6):614–622

    Article  PubMed  CAS  Google Scholar 

  20. Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X et al (2005) Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 14(7):534–542

    Article  PubMed  Google Scholar 

  21. Yaqub S, Moder KG, Lacy MQ (2004) Severe, reversible pulmonary hypertension in a patient with monoclonal gammopathy and features of dermatomyositis. Mayo Clin Proc 79(5):687–689

    Article  PubMed  Google Scholar 

  22. Grateau G, Roux ME, Franck N et al (1993) Pulmonary hypertension in a case of dermatomyositis. J Rheumatol 20(8):1452–1453

    PubMed  CAS  Google Scholar 

  23. Kissel JT, Mendell JR, Rammohan KW (1986) Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 314(6):329–334

    PubMed  CAS  Google Scholar 

  24. Wakata N, Kurihara T, Saito E, Kinoshita M (2002) Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 41(11):729–734

    Article  PubMed  Google Scholar 

  25. Hill CL, Zhang Y, Sigurgeirsson B et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357(9250):96–100

    Article  PubMed  CAS  Google Scholar 

  26. Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326(6):363–367

    Article  PubMed  CAS  Google Scholar 

  27. Bernatsky S, Boivin JF, Joseph L et al (2005) An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52(5):1481–1490

    Article  PubMed  CAS  Google Scholar 

  28. Bernatsky S, Clarke AE, Suissa S (2008) Haematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med 168(4):378–381

    Article  PubMed  Google Scholar 

  29. Biro E, Szekanecz Z, Czirjak L et al (2006) Association of systemic and thyroid autoimmune diseases. Clin Rheumatol 25(2):240–245

    Article  PubMed  Google Scholar 

  30. Koh ET, Seow A, Ong B, Ratnagopal P, Tjia H, Chng HH (1993) Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 52(12):857–861

    Article  PubMed  CAS  Google Scholar 

  31. Shamim EA, Miller FW (2000) Familial autoimmunity and the idiopathic inflammatory myopathies. Curr Rheumatol Rep 2(3):201–211

    Article  PubMed  CAS  Google Scholar 

  32. Marie I, Hachulla E, Cherin P et al (2005) Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53(2):155–165

    Article  PubMed  Google Scholar 

  33. Viguier M, Fouere S, de la Salmoniere P et al (2003) Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine (Baltimore) 82(2):82–86

    Article  Google Scholar 

  34. Ishida Y, Utikoshi M, Kurosaki M et al (1998) Hepatic veno-occlusive disease in a case of polymyositis associated with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Intern Med 37(8):694–699

    Article  PubMed  CAS  Google Scholar 

  35. Miller FW, Rider LG, Chung YL et al (2001) International Myositis Outcome Assessment Collaborative Study Group. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 40(11):1262–1273

    Article  CAS  Google Scholar 

  36. Isenberg DA, Allen E, Farewell V et al (2004) International Myositis and Clinical Studies Group (IMACS). International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43(1):49–54

    Article  CAS  Google Scholar 

  37. Sultan SM, Allen E, Oddis CV et al (2008) Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum 58(11):3593–3599

    Article  PubMed  Google Scholar 

  38. Shamim EA, Rider LG, Pandey JP et al (2002) Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum 46(7):1885–1893

    Article  PubMed  Google Scholar 

  39. O'Hanlon TP, Rider LG, Mamyrova G et al (2006) HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 54(11):3670–3681

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

Dr. Kristine P. Ng is a recipient of the New Zealand Rose Hellaby medical scholarship.

Disclosures

None

Author information

Authors and Affiliations

  1. Centre for Rheumatology, Department of Medicine, Windeyer Institute, University College London, Room 331, 3rd floor, 46 Cleveland Street, London, W1T 4JF, UK

    K. P. Ng, S. M. Sultan & D. A. Isenberg

  2. Rheumatology Department, Santa Maria Hospital, Lisbon, Portugal

    F. Ramos

Authors
  1. K. P. Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Ramos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. M. Sultan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. A. Isenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. A. Isenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ng, K.P., Ramos, F., Sultan, S.M. et al. Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up. Clin Rheumatol 28, 947–953 (2009). https://doi.org/10.1007/s10067-009-1181-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1181-4

Keywords

Search

Navigation